FDA Inspection 1128908 — PTC Therapeutics, Inc.
The FDA completed an inspection of PTC Therapeutics, Inc. on August 12, 2020 in Warren, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 12, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warren, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)